Inactive Instrument

Wockhardt Bio AG

WBIO

CH0193042501

Wockhardt Ltd. cancelled the acquisition of Wockhardt France S.A.S. from Wockhardt Bio AG.

November 09, 2017

Wockhardt Ltd. (BSE:532300) agreed to acquire Wockhardt France (Holdings) S.A.S. from Wockhardt Bio AG (BRSE:WBIO) on November 10, 2016. Wockhardt Ltd.'s Board of Directors have approved the transaction.

Wockhardt Ltd. (BSE:532300) cancelled the acquisition of Wockhardt France (Holdings) S.A.S. from Wockhardt Bio AG (BRSE:WBIO) on November 10, 2017.

Latest news about Wockhardt Bio AG

Wockhardt Bio AG Reports Earnings Results for the Full Year Ended March 31, 2022	22-07-12	CI
Wockhardt Bio Ag and Jiangxi Jemincare Group Company Limited, China ("Jemincare"), Partnered for Wockhardt's Novel Patented Antibiotic Wck 4873	21-08-25	CI
Wockhardt Bio AG Reports Earnings Results for the Full Year Ended March 31, 2021	21-06-07	CI
Wockhardt Bio AG Announces Audited Earnings Results for the Year Ended March 31, 2020	20-07-05	CI
Wockhardt Ltd. cancelled the acquisition of Wockhardt France S.A.S. from Wockhardt Bio AG.	17-11-09	CI
Wockhardt Ltd. agreed to acquire Wockhardt France S.A.S. from Wockhardt Bio AG.	16-11-09	CI
Wockhardt Bio AG Avails Secure Term Loan of $250 Million Facility	16-07-01	CI
Wockhardt Bio AG has completed an IPO in the amount of CHF 11.8574 million.	13-12-18	CI

Chart Wockhardt Bio AG

Duration

Period

More charts

Company Profile

Wockhardt Bio AG is a Germany-based pharmaceutical company. It is active in the development, manufacturing and marketing of pharmaceutical and biopharmaceutical formulations. It offers a portfolio of generic drugs, which includes approximately 600 pharmaceuticals in various dosages and forms. Its offering covers several therapeutic categories, such as central nervous system agents, hormones, cardiovascular agents, anti-infective and respiratory agents, as well as gastrointestinal, dermatological and biological agents. The Company supplies markets in the United States, the United Kingdom, Ireland, France and Latin America. Additionally, it exports its pharmaceutical products to over 50 countries.

Sector

Pharmaceuticals

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.28%	44.4B
OTSUKA HOLDINGS CO., LTD.	+24.60%	23.03B
SANDOZ GROUP AG	+18.48%	15.14B
CIPLA LIMITED	+12.87%	13.12B
ZYDUS LIFESCIENCES LIMITED	+44.67%	11.85B
ONO PHARMACEUTICAL CO., LTD.	-8.33%	6.99B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+12.22%	5.52B

Generic Pharmaceuticals